外资再加码!医药巨头阿斯利康核药生产供应基地落子黄埔

21世纪经济报道
Mar 19

3月19日,阿斯利康与广州经济技术开发区管理委员会正式签署战略合作框架协议,宣布将在广州开发区、黄埔区建设放射性偶联药物(RDC)生产供应基地。这是阿斯利康今年1月宣布系列投资中的重要一环,标志着这家全球生物医药巨头在核药这一前沿赛道完成战略布局的关键落子。  阿斯利康(LSE/STO/NYSE: AZN)是一家科学至上的全球生物制药企业,专注于肿瘤、罕见病及涵盖心血管、肾脏及代谢、呼吸及免疫等...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10